Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015–2020
Author:
Jeyashree KathiresanORCID, Thangaraj Jeromie, Rade Kiran, Modi Bhavesh, Selvaraju Sriram, Velusamy Saravanakumar, Akhil Sasidharan, Vijayageetha Mathavaswami, Sudha Rani Dhanapal, Sabarinathan Ramasamy, Manikandanesan Sakthivel, Elumalai Rajalakshmi, Natarajan MeenakumariORCID, Joseph Bency, Mahapatra Amarendra, Shamim Almas, Shah Amar, Bhardwaj Ashok, Purty Anil, Vadera Bhavin, Sridhar Anand, Chowdhury Aniket, Shafie Asif, Choudhury Avijit, Dhrubjyoti Deka, Solanki Hardik, Sirmanwar Krushna, Khaparde Kshitij, Parmar Malik, Dahiya Nisha, Debdutta Parija, Ahmed Quazi, Ramachandran Ranjani, Prasad Ranjeet, Shinde Rohini, Baruah Rupali, Chauhan Sandeep, Bharaswadkar Sandip, Achanta Shanta, Sharath Burugina Nagaraja, Balakrishnan ShibuORCID, Chandra Shivani, Khumukcham Sophia, Mandal Sudarsan, Chalil Sumitha, Shah Vaibhav, Roddawar Venkatesh, Rao Raghuram, Sachdeva Kuldeep, Murhekar ManojORCID
Abstract
ObjectivesWe verified subnational (state/union territory (UT)/district) claims of achievements in reducing tuberculosis (TB) incidence in 2020 compared with 2015, in India.DesignA community-based survey, analysis of programme data and anti-TB drug sales and utilisation data.SettingNational TB Elimination Program and private TB treatment settings in 73 districts that had filed a claim to the Central TB Division of India for progress towards TB-free status.ParticipantsEach district was divided into survey units (SU) and one village/ward was randomly selected from each SU. All household members in the selected village were interviewed. Sputum from participants with a history of anti-TB therapy (ATT), those currently experiencing chest symptoms or on ATT were tested using Xpert/Rif/TrueNat. The survey continued until 30 Mycobacterium tuberculosis cases were identified in a district.Outcome measuresWe calculated a direct estimate of TB incidence based on incident cases identified in the survey. We calculated an under-reporting factor by matching these cases within the TB notification system. The TB notification adjusted for this factor was the estimate by the indirect method. We also calculated TB incidence from drug sale data in the private sector and drug utilisation data in the public sector. We compared the three estimates of TB incidence in 2020 with TB incidence in 2015.ResultsThe estimated direct incidence ranged from 19 (Purba Medinipur, West Bengal) to 1457 (Jaintia Hills, Meghalaya) per 100 000 population. Indirect estimates of incidence ranged between 19 (Diu, Dadra and Nagar Haveli) and 788 (Dumka, Jharkhand) per 100 000 population. The incidence using drug sale data ranged from 19 per 100 000 population in Diu, Dadra and Nagar Haveli to 651 per 100 000 population in Centenary, Maharashtra.ConclusionTB incidence in 1 state, 2 UTs and 35 districts had declined by at least 20% since 2015. Two districts in India were declared TB free in 2020.
Funder
Central TB division, Ministry of Health & Family Welfare, India
Reference20 articles.
1. National strategic plan for tuberculosis elimination 2017–2025, 2017. New Delhi. Available: https://tbcindia.gov.in/WriteReadData/NSP Draft 20.02.2017 1.pdf 2. India TB report 2020, 2020. New Delhi. Available: www.tbcindia.gov.in [Accessed 19 Apr 2021]. 3. TB notification rates across parliamentary constituencies in India: a step towards data-driven political engagement;Pardeshi;Trop Med Int Health,2021 4. Golandaj JA , Naikar SK , Hallad JS . Trends and sub-national disparities in TB notifications in India: insights from HMIS data. Indian J Tuberc.doi:10.1016/J.IJTB.2021.04.005 5. Inverse sampling to study disease burden of leprosy;Aggarwal;Indian J Med Res,2010
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|